GEMCITABINE

作品数：313被引量：907H指数：11
导出分析报告
相关领域：医药卫生更多>>
相关作者：贾林巴一黄鼎智韩如冰李鸿立更多>>
相关机构：中山大学广州医学院天津医科大学广州市第一人民医院更多>>
相关期刊：更多>>
相关基金：国家自然科学基金中国博士后科学基金广东省社会发展领域科技计划项目国家重点基础研究发展计划更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=World Journal of Clinical Casesx
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Conversion surgery after gemcitabine and cisplatin plus durvalumab for advanced intrahepatic cholangiocarcinoma:A case report被引量：1
《World Journal of Clinical Cases》2024年第34期6721-6727,共7页Yu Igata Masashi Kudo Motohiro Kojima Shota Kami Keishiro Aoki Tomoyuki Satake Tatsushi Kobayashi Motokazu Sugimoto Shin Kobayashi Masaru Konishi Naoto Gotohda 
BACKGROUND The combination of immune checkpoint inhibitors and chemotherapy has shown promising results for the treatment of advanced biliary tract cancer(BTC).Based on the results of the TOPAZ-1 trial,a gemcitabine a...
关键词：Conversion surgery Intrahepatic cholangiocarcinoma Small duct type Immunotherapy Case report 
Evaluation of response to gemcitabine plus cisplatin-based chemotherapy using positron emission computed tomography for metastatic bladder cancer
《World Journal of Clinical Cases》2023年第36期8447-8457,共11页HakanÖztürk İnançKarapolat 
BACKGROUND The purpose of the present study was to examine retrospectively the contribution of 18Fluorodeoxyglucose positron emission tomography computed tomography(18FDG-PET/CT)to the evaluation of response to first-...
关键词：Metastatic bladder cancer Response to chemotheraphy Positron emission tomography computed tomography 18FDG-PET/CT 
Rare ROS1-CENPW gene in pancreatic acinar cell carcinoma and the effect of crizotinib plus AG chemotherapy:A case report
《World Journal of Clinical Cases》2023年第24期5823-5829,共7页Tao Wang Yi-Yu Shen 
BACKGROUND This is the first report of an ROS1-CENPW fusion gene in pancreatic malignancies.CASE SUMMARY A 77-year-old woman with a pancreatic tumor and multiple liver metastases was admitted to our hospital.Genetic t...
关键词：ROS1-CENPW Pancreatic acinar cell carcinoma CRIZOTINIB GEMCITABINE Albumin paclitaxel Case report 
Gemcitabine-induced peripheral vascular disease and prolonged response in a patient with metastatic pancreatic adenocarcinoma:A case report
《World Journal of Clinical Cases》2023年第6期1372-1378,共7页Moinard-Butot Fabien Poprawa Elodie Schohn Anna Pietro Addeo Benabdelghani Meher 
BACKGROUND Gemcitabine is an antimetabolite used in the treatment of pancreatic cancer.One of the side effects of gemcitabine is vascular toxicity.Here,we report the case of a patient treated with gemcitabine who had ...
关键词：GEMCITABINE Pancreatic cancer Peripheral vascular disease Prolonged tumor response Case report 
Bladder preservation in complicated invasive urothelial carcinoma following treatment with cisplatin/gemcitabine plus tislelizumab:A case report
《World Journal of Clinical Cases》2023年第5期1165-1174,共10页Rui Yang Jun-Xing Chen Shu-Hang Luo Ting-Ting Chen Ling-Wu Chen Bin Huang 
BACKGROUND Invasive urothelial carcinoma(UC)with squamous and glandular differentiation is a highly malignant and complicated pathological subtype,and the standard care is radical cystectomy(RC).However,urinary divers...
关键词：Invasive urothelial carcinoma Immunotherapy Chemotherapy Squamous and glandular differentiation Tislelizumab Case report 
Meta-analysis of gemcitabine plus nab-paclitaxel combined with targeted agents in the treatment of metastatic pancreatic cancer
《World Journal of Clinical Cases》2022年第27期9703-9713,共11页Zhong-Hui Li Yin-Jie Ma Zong-Hang Jia Yue-Yan Weng Ping Zhang Shi-Jie Zhu Fang Wang 
BACKGROUND Gemcitabine plus nab-paclitaxel(GA) is a commonly used first-line treatment regimen for metastatic pancreatic cancer,and many studies will add a novel targeted agent to this regimen for improving patient su...
关键词：Metastatic pancreatic cancer GEMCITABINE NAB-PACLITAXEL Novel targeted agent SURVIVAL 
Concurrent chemoradiotherapy using gemcitabine and nedaplatin in recurrent or locally advanced head and neck squamous cell carcinoma
《World Journal of Clinical Cases》2022年第11期3414-3425,共12页Rui-Xue Huo Ying-Ying Jin Yong-Xue Zhuo Xiao-Tong Ji Yu Cui Xiao-Jing Wu Yi-Jia Wang Long Zhang Wen-Hua Zhang Yu-Mei Cai Cheng-Cheng Zheng Rui-Xue Cui Qian-Ye Wang Zhen Sun Feng-Wei Wang 
Supported by Tianjin Science and Technology Plan Project,No. 19YFZCSY00170;Tianjin Union Medical center,No. 2019YJ007;Beijing medical and health foundation,No. F1814B
BACKGROUND Patients with recurrent or locally advanced head and neck squamous cell carcinoma(HNSCC)typically have limited treatment options and poor prognosis.AIM To evaluate the efficacy and safety of two drugs with ...
关键词：CHEMORADIOTHERAPY GEMCITABINE NEDAPLATIN Head and neck cancer RECURRENT Locally advanced 
Efficacy and safety of S-1 maintenance therapy in advanced nonsmall- cell lung cancer patients被引量：2
《World Journal of Clinical Cases》2020年第21期5172-5179,共8页Xiao-Wei Cheng Wen-Hua Leng Chun-Ling Mu 
BACKGROUND Previous reports have demonstrated that S-1 has remarkable effects in the maintenance treatment of advanced non-small-cell lung cancer(NSCLC),and has less toxic and side effects than conventional drugs.AIM ...
关键词：Advanced non-small cell lung cancer Maintenance therapy S-1 GEMCITABINE EFFICACY Toxic and side effects 
Gemcitabine plus concurrent irreversible electroporation vs gemcitabine alone for locally advanced pancreatic cancer被引量：7
《World Journal of Clinical Cases》2020年第22期5564-5575,共12页Yang-Yang Ma Yin Leng Yan-Li Xing Hong-Mei Li Ji-Bing Chen Li-Zhi Niu 
Supported by International Science Foundation of Affiliated Fuda Cancer Hospital,Jinan University,No.Y2018-ZD-01.
BACKGROUND Locally advanced pancreatic cancer(LAPC)is a common malignant digestive system tumor that ranks as the fourth leading cause of cancer-related death in the world.The prognosis of LAPC is poor even after stan...
关键词：Irreversible electroporation GEMCITABINE Locally advanced pancreatic cancer Overall survival Progression free survival Prognostic factors 
Intravesically instilled gemcitabine-induced lung injury in a patient with invasive urothelial carcinoma: A case report
《World Journal of Clinical Cases》2020年第19期4652-4659,共8页Xiao-Ming Zhou Cen Wu Xiu Gu 
BACKGROUND Gemcitabine is a chemotherapy agent with relatively low toxicities,as a valid option for elderly patients with underlying diseases.Gemcitabine-induced pulmonary toxicities are rare and various,ranging from ...
关键词：GEMCITABINE Interstitial lung disease Lung injury Organizing pneumonitis Urothelial carcinoma Case report Chemotherapy toxicity 
全选清除导出
共2页<12>
检索报告 对象比较 聚类工具 使用帮助 返回顶部